Silver nanoparticles (AgNPs) have extensive applications in nanomedicine due to their physicochemical properties and interactions with biomolecules. One way of obtaining them is through green synthesis with plant extracts containing reducing and capping agents, such as Catharanthus roseus (L.) G Don. This plant has pharmacological applications due to its phytocompounds with biological activity. The C. roseus flowers are rich in alkaloids and phenolic compounds, and have the potential to synthesize AgNPs but have never been used with this purpose. In this study, AgNPs were synthesize with the aqueous extract from the C. roseus flowers, and their cytotoxicity evaluated on A549 lung tumor cells through MTT assay. The AgNP synthesis could be seen visually from the solution's color change and through UV-visible spectroscopy to detect a peak between 400 - 530 nm. FEG microscopy showed AgNPs with variable shapes and sizes. In vitro cytotoxicity assay against A549 cells showed that the C. roseus extract have low toxicity to the lineage, and AgNPs reduced half the viable cells at the 1.5% concentration, demonstrating high cytotoxicity. Therefore, AgNPs from C. roseus were successfully obtained and showed significant cytotoxic activity on A549 lung cancer cells.
This work reports a new application for a well-known medicinal plant used in Brazil. The green synthesis of silver nanoparticles (AgNPs) using the aqueous extract of Monteverdia ilicifolia (MI) leaves as stabilizing and reducing agent is described. The AgNPs-MI obtained were characterized by UV-VIS, FTIR, and Raman spectroscopies, DLS, zeta potential and FEG-SEM, which demonstrated that M. ilicifolia was effective at capping the AgNPs, yielding stable suspensions. These nanoparticles were deposited on glassy carbon electrodes, and they were efficiently applied as electrochemical sensors for the determination of dopamine (DA) using square wave voltammetry (SWV). The AgNPs-MI improved the electrochemical properties of the electrodes and enhanced their electroanalytical performance. The developed sensing device presented detection and quantification limits equal to 0.52 and 1.74 μmol L–1, respectively, towards DA determination. The proposed electrochemical sensor quantified this neurotransmitter successfully, confirming its potential as a new promising analytical detection tool for DA quality control.